Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

Completed · Phase 2

Conditions studied: Esophageal Reflux

In brief

The purpose of this study is to determine the production of mucin in GERD/RE subjects before and after 8 weeks of treatment with rabeprazole.

Key facts

Study ID

NCT00222170

Run by

University of Kansas

People needed

24

Starts

2005-05-01

Expected to finish

2007-05-01

Last updated by the study team

2009-05-08

Who can join

Age: 19 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.